Amyris announces proposed public offering (secondary and primary) of common stock

Emeryville, calif., april 7, 2021 /prnewswire/ -- amyris, inc. (nasdaq: amrs) ("amyris"), a leading synthetic biotechnology company active in the clean health and beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the commencement of a proposed underwritten public offering of shares of its common stock.
AMRS Ratings Summary
AMRS Quant Ranking